[go: up one dir, main page]

DE3476885D1 - Novel corticoid derivatives and process for production thereof - Google Patents

Novel corticoid derivatives and process for production thereof

Info

Publication number
DE3476885D1
DE3476885D1 DE8484110572T DE3476885T DE3476885D1 DE 3476885 D1 DE3476885 D1 DE 3476885D1 DE 8484110572 T DE8484110572 T DE 8484110572T DE 3476885 T DE3476885 T DE 3476885T DE 3476885 D1 DE3476885 D1 DE 3476885D1
Authority
DE
Germany
Prior art keywords
derivatives
production
novel
eczema
novel corticoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8484110572T
Other languages
English (en)
Inventor
Issei Nitta
Kenichiro Nakao
Motoyoshi Miyake
Akira Maruyama
Junko Takashima
Hiroaki Mitsubishi Kasei Ueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Kasei Corp
Original Assignee
Mitsubishi Kasei Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP58164772A external-priority patent/JPS6056997A/ja
Priority claimed from JP59120439A external-priority patent/JPS611698A/ja
Application filed by Mitsubishi Kasei Corp filed Critical Mitsubishi Kasei Corp
Application granted granted Critical
Publication of DE3476885D1 publication Critical patent/DE3476885D1/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE8484110572T 1983-09-07 1984-09-05 Novel corticoid derivatives and process for production thereof Expired DE3476885D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP58164772A JPS6056997A (ja) 1983-09-07 1983-09-07 新規な6−酸素化コルチコイド/7α−カ−ボネ−ト誘導体およびその製法
JP59120439A JPS611698A (ja) 1984-06-12 1984-06-12 新規なコルチコイド誘導体およびその製法

Publications (1)

Publication Number Publication Date
DE3476885D1 true DE3476885D1 (en) 1989-04-06

Family

ID=26458022

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484110572T Expired DE3476885D1 (en) 1983-09-07 1984-09-05 Novel corticoid derivatives and process for production thereof

Country Status (9)

Country Link
EP (1) EP0136586B1 (de)
AT (1) ATE41013T1 (de)
AU (1) AU558725B2 (de)
DD (3) DD229135A5 (de)
DE (1) DE3476885D1 (de)
DK (1) DK168631B1 (de)
HU (2) HU201092B (de)
NO (1) NO843548L (de)
SU (2) SU1561827A3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4025342A1 (de) * 1990-08-10 1992-02-13 Hoechst Ag In 17-stellung substituierte corticoid-17-alkylcarbonate, verfahren zu deren herstellung und diese enthaltende arzneimittel
WO1997041145A1 (en) 1996-05-01 1997-11-06 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services 21-substituted progesterone derivatives as new antiprogestational agents
US6900193B1 (en) 1996-05-01 2005-05-31 The United States Of America As Represented By The Department Of Health And Human Services Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1518179B1 (de) * 1964-10-07 1970-01-02 Warner Lambert Pharmaceutical Verfahren zur Herstellung von 17alpha-Acyloxy-20-keto-21-desoxy-steroiden
US3558675A (en) * 1969-06-30 1971-01-26 Merck & Co Inc Steroid carbonates and process
GB1440063A (en) * 1972-08-11 1976-06-23 Glaxo Lab Ltd 17alpha-esters of 17alpha,21-dihydroxy-20-oxo-steroids
DE2735110A1 (de) * 1977-08-04 1979-02-15 Hoechst Ag Corticoid-17-alkylcarbonate und verfahren zu ihrer herstellung
DE2817988A1 (de) * 1978-04-25 1979-11-08 Hoechst Ag Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
DE3133082A1 (de) * 1981-08-18 1983-03-10 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue hydrocortison-derivate, ihre herstellung und verwendung

Also Published As

Publication number Publication date
DD229702A5 (de) 1985-11-13
DK168631B1 (da) 1994-05-09
AU3231184A (en) 1985-03-14
EP0136586B1 (de) 1989-03-01
DK407384D0 (da) 1984-08-24
EP0136586A2 (de) 1985-04-10
DD229135A5 (de) 1985-10-30
ATE41013T1 (de) 1989-03-15
DD232497A5 (de) 1986-01-29
EP0136586A3 (en) 1986-01-29
HUT37944A (en) 1986-03-28
AU558725B2 (en) 1987-02-05
HUT44040A (en) 1988-01-28
NO843548L (no) 1985-03-08
HU201092B (en) 1990-09-28
DK407384A (da) 1985-03-08
SU1551250A3 (ru) 1990-03-15
SU1561827A3 (ru) 1990-04-30

Similar Documents

Publication Publication Date Title
ES549012A0 (es) Procedimiento para la produccion de derivados diarilicos de compuestos antiinflamatorios antialergicos.
GR3035001T3 (en) Nitric oxide donor composition and method for treatment of anal disorders
CA2148928A1 (en) Pharmacologically active pyridine derivatives and processes for the preparation thereof
AU5593586A (en) Process for the production of 2,2,6,6,-tetraalkyl 4 piperidylamines
IT1212085B (it) I singoli fattori 1, 2, 3, 4 e 5della teicomicina a2 puri ed il metodo per la loro produzione.
CA1015552A (en) Method and manufacturing a steering knuckle and spindle
AU6857887A (en) Therapeutic agent
AU1340895A (en) Fatty acid derivatives
ES2001578A6 (es) Procedimiento para la fabricacion continua de esterillas absorbentes para panales
DE3476885D1 (en) Novel corticoid derivatives and process for production thereof
ATA900589A (de) Stereospezifisches verfahren fuer die herstellung von enantiomeren des 3-substituierten furo (3,4-c) pyridins, so erhaltene enantiomere oder mischungen davon sowie diese enthaltene therapeutische mittel
NO870998L (no) FremgangsmŸte for fremstilling av nye, terapeutisk aktive acetamid-derivater.
AU3474784A (en) Purine derivatives
ES8407476A1 (es) Procedimiento de preparar compuestos piridinicos.
PH27409A (en) Benzocycloalkylaminopyrimidines and related compounds as topical antiinflammatory agents for the treatment of skin disorders
EP0159040A3 (en) Pyridine derivatives and production thereof
HUT55003A (en) Process for producing acyl derivatives of hydroxy-pyrimidines
IE810808L (en) Isophthalic acid picolylamide monohydrate
ES467704A1 (es) Procedimiento para la obtencion de derivados de 2,2-dioxido de 2,1,3-tiadiazin-4-ona.
GB8917138D0 (en) Process for the production of stable dispersions,the dispersions so produced,and the use thereof in the manufacture of polyurethanes
AU4514389A (en) 2-aminocarboxylic acid derivatives, their manufacture and use as drugs
GB1552982A (en) Process for the production of 3-hydroxy 1,2,4-triazole derivatives
KR870700627A (ko) 세팔로스포린 유도체의 신규 제조방법
BE848180A (fr) Procede de fabrication d'articles decoratifs et articles ainsi obtenus,
ES545670A0 (es) Un procedimiento para la preparacion de una hidroxiaminoce- tona

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee